Interleukin-1 family

From WikiMD's WELLNESSPEDIA

(Redirected from Interleukin-1)


Overview[edit]

The Interleukin-1 family is a group of 11 cytokines, which plays a central role in the regulation of immune and inflammatory responses to infections or sterile insults. These cytokines are part of the larger interleukin family and are primarily produced by activated macrophages, as well as other cell types such as dendritic cells, fibroblasts, and some epithelial cells.

Members of the Interleukin-1 Family[edit]

The Interleukin-1 family consists of the following members:

Structure and Function[edit]

Structure of Interleukin-1 beta (IL-1_)

The members of the Interleukin-1 family are characterized by their similar structure, which includes a conserved beta-trefoil fold. This structural motif is crucial for their interaction with specific cytokine receptors.

IL-1_ and IL-1_ are the most studied members of this family and are known for their potent pro-inflammatory effects. They bind to the Interleukin-1 receptor type I (IL-1RI) and recruit the Interleukin-1 receptor accessory protein (IL-1RAcP) to initiate signaling cascades that lead to the activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-_B) and mitogen-activated protein kinases (MAPKs).

Biological Roles[edit]

The Interleukin-1 family cytokines are involved in a wide range of biological processes, including:

  • Inflammation: IL-1_ is a key mediator of the inflammatory response, promoting the expression of adhesion molecules, chemokines, and other pro-inflammatory cytokines.
  • Fever: IL-1_ acts on the hypothalamus to induce fever, a common response to infection.
  • Immune Response: These cytokines enhance the proliferation and differentiation of T cells and B cells, thus playing a crucial role in adaptive immunity.
  • Tissue Repair: Some members, like IL-33, are involved in tissue repair and homeostasis.

Clinical Significance[edit]

Dysregulation of Interleukin-1 family cytokines is associated with various diseases, including autoimmune disorders, chronic inflammatory diseases, and cancer. For instance, excessive production of IL-1_ is implicated in conditions such as rheumatoid arthritis, gout, and type 2 diabetes.

Therapeutic strategies targeting the Interleukin-1 pathway, such as the use of IL-1 receptor antagonists, have been developed to treat these conditions.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.